Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sally W Wade

Showing results (21-30 of 53) with videos related to

Pageof 6
Sort By:
Breast Cancer Research and Treatment|July 24, 2014
Prevalence of women with early-stage breast cancer receiving active management using electronic health records from oncology clinics in the United StatesRohini K Hernandez, David Quach, Sally W Wade, et al.
BMC Pediatrics|October 14, 2014
Partial palivizumab prophylaxis and increased risk of hospitalization due to respiratory syncytial virus in a Medicaid population: a retrospective cohort analysisLeonard R Krilov, Anthony S Masaquel, Leonard B Weiner, et al.
Journal of Affective Disorders|July 4, 2025
Health care resource utilization and costs associated with switching versus augmenting antidepressant monotherapy in second-line treatment of major depressive disorderPrakash S Masand, Nadia Nabulsi, François Laliberté, et al.
American Journal of Perinatology|April 17, 2020
Unintended Consequences Following the 2014 American Academy of Pediatrics Policy Change for Palivizumab Prophylaxis among Infants Born at Less than 29 Weeks' GestationMitchell Goldstein, Leonard R Krilov, Jaime Fergie, et al.
Journal of Medical Economics|February 26, 2021
Cost-effectiveness for KTE-X19 CAR T therapy for adult patients with relapsed/refractory mantle cell lymphoma in the United StatesClaire L Simons, Daniel Malone, Michael Wang, et al.
American Journal of Perinatology|September 8, 2017
The 2014-2015 National Impact of the 2014 American Academy of Pediatrics Guidance for Respiratory Syncytial Virus Immunoprophylaxis on Preterm Infants Born in the United StatesAmanda M Kong, Leonard R Krilov, Jaime Fergie, et al.
Clinical and Experimental Medicine|January 14, 2026
Patient-reported disease burden and health care utilization of HAE-nl-C1INH: insights from a real-world surveyDouglas Jones, Nihal Narsipur, Sally W Wade, et al.
Clinical Epidemiology|August 1, 2015
Prevalence of bone metastases and bone-targeting agent use among solid tumor patients in the United StatesRohini K Hernandez, Avanti Adhia, Sally W Wade, et al.
Cancer Medicine|February 10, 2015
Prevalence of renal impairment and use of nephrotoxic agents among patients with bone metastases from solid tumors in the United StatesJorge Arellano, Rohini K Hernandez, Sally W Wade, et al.
Oncoimmunology|December 8, 2018
An observational study of concomitant immunotherapies and denosumab in patients with advanced melanoma or lung cancerAlexander Liede, Rohini K Hernandez, Sally W Wade, et al.
Pageof 6

Showing results (21-30 of 53) with videos related to

Sort By:
Pageof 6
Breast Cancer Research and Treatment|July 24, 2014
Prevalence of women with early-stage breast cancer receiving active management using electronic health records from oncology clinics in the United StatesRohini K Hernandez, David Quach, Sally W Wade, et al.
BMC Pediatrics|October 14, 2014
Partial palivizumab prophylaxis and increased risk of hospitalization due to respiratory syncytial virus in a Medicaid population: a retrospective cohort analysisLeonard R Krilov, Anthony S Masaquel, Leonard B Weiner, et al.
Journal of Affective Disorders|July 4, 2025
Health care resource utilization and costs associated with switching versus augmenting antidepressant monotherapy in second-line treatment of major depressive disorderPrakash S Masand, Nadia Nabulsi, François Laliberté, et al.
American Journal of Perinatology|April 17, 2020
Unintended Consequences Following the 2014 American Academy of Pediatrics Policy Change for Palivizumab Prophylaxis among Infants Born at Less than 29 Weeks' GestationMitchell Goldstein, Leonard R Krilov, Jaime Fergie, et al.
Journal of Medical Economics|February 26, 2021
Cost-effectiveness for KTE-X19 CAR T therapy for adult patients with relapsed/refractory mantle cell lymphoma in the United StatesClaire L Simons, Daniel Malone, Michael Wang, et al.
American Journal of Perinatology|September 8, 2017
The 2014-2015 National Impact of the 2014 American Academy of Pediatrics Guidance for Respiratory Syncytial Virus Immunoprophylaxis on Preterm Infants Born in the United StatesAmanda M Kong, Leonard R Krilov, Jaime Fergie, et al.
Clinical and Experimental Medicine|January 14, 2026
Patient-reported disease burden and health care utilization of HAE-nl-C1INH: insights from a real-world surveyDouglas Jones, Nihal Narsipur, Sally W Wade, et al.
Clinical Epidemiology|August 1, 2015
Prevalence of bone metastases and bone-targeting agent use among solid tumor patients in the United StatesRohini K Hernandez, Avanti Adhia, Sally W Wade, et al.
Cancer Medicine|February 10, 2015
Prevalence of renal impairment and use of nephrotoxic agents among patients with bone metastases from solid tumors in the United StatesJorge Arellano, Rohini K Hernandez, Sally W Wade, et al.
Oncoimmunology|December 8, 2018
An observational study of concomitant immunotherapies and denosumab in patients with advanced melanoma or lung cancerAlexander Liede, Rohini K Hernandez, Sally W Wade, et al.
Pageof 6